Probing the Origin of the Toxicity of Oligomeric Aggregates of α-Synuclein with Antibodies
Lists
Only you see this
Abstract
The aggregation of α-synuclein, a protein involved in neurotransmitter release at presynaptic terminals, is associated with a range of highly debilitating neurodegenerative conditions, most notably Parkinson's disease. Intraneuronal inclusion bodies, primarily composed of α-synuclein fibrils, are the major histopathological hallmarks of these disorders, although small oligomeric assemblies are believed to play a crucial role in neuronal impairment. We have probed the mechanism of neurotoxicity of α-synuclein oligomers isolated in vitro using antibodies targeting the N-terminal region of the protein and found that the presence of the antibody resulted in a substantial reduction of the damage induced by the aggregates when incubated with primary cortical neurons and neuroblastoma cells. We observed a similar behavior in vivo using a strain of C. elegans overexpressing α-synuclein, where the aggregation process itself is also partially inhibited as a result of incubation with the antibodies. The similar effects of the antibodies in reducing the toxicity of the aggregated species formed in vitro and in vivo provide evidence for a common origin of cellular impairment induced by α-synuclein aggregates.
BibTeX
@inproceedings{cascella2019probing,
author = {Roberta Cascella and Michele Perni and Serene W. Chen and Giuliana Fusco and Cristina Cecchi and Michele Vendruscolo and Fabrizio Chiti and Christopher M. Dobson and Alfonso De Simone},
title = {{Probing the Origin of the Toxicity of Oligomeric Aggregates of α-Synuclein with Antibodies}},
booktitle = {ACS},
year = {2019},
doi = {10.1021/acschembio.9b00312},
}Loading related content...